Mary T. Szela - Jun 22, 2021 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Marc Grasso, Attorney-in-fact for Mary Szela
Stock symbol
KURA
Transactions as of
Jun 22, 2021
Transactions value $
$0
Form type
4
Date filed
6/23/2021, 05:19 PM
Next filing
Jul 29, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +23K $0.00 23K Jun 22, 2021 Common Stock 23K $21.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in full on the one year anniversary of the date of grant.